Biology of Brain Tumour
Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24¿26, 1984)
Herausgeber: Thomas, David G.T., Walker, Michael D.
Biology of Brain Tumour
Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24¿26, 1984)
Herausgeber: Thomas, David G.T., Walker, Michael D.
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This volume contains the proceedings of the Second International Symposium on Biology of Brain Tumour. The first Symposium was held in 1979 at Gardonne Riviera, Italy. This meeting was planned in order to coincide with the lOOth Anniversary of the first reported operation for glioma in London on November 25, 1884. Since the first meeting, the field of neuro-oncology has made remarkable progress in understanding both basic and clinical factors of significance to patients with brain tumor. While the earlier meeting dealt to a large extent with clinically oriented studies, this symposium was more…mehr
- Donald S. CoffeyA Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer153,99 €
- Gilles PlourdeProstate Cancer77,99 €
- NathansonCurrent Research and Clinical Management of Melanoma236,99 €
- Bharat B. Mittal / James A. Purdy / K.K. Ang (Hgg.)Advances in Radiation Therapy236,99 €
- PollockSurgical Oncology409,99 €
- Neil Bruce / Isabel Gamboa-deBuen / Mercedes Rodriguez-Villafuerte (Hgg.)Medical Physics: Seventh Mexican Symposium on Medical Physics152,99 €
- Neurosurgical Neuropsychology111,99 €
-
-
-
- Produktdetails
- Verlag: Springer, Berlin
- 1986
- Seitenzahl: 528
- Erscheinungstermin: 31. Oktober 1986
- Englisch
- Abmessung: 266mm x 200mm x 33mm
- Gewicht: 1317g
- ISBN-13: 9780898387759
- ISBN-10: 0898387752
- Artikelnr.: 22923682
- Verlag: Springer, Berlin
- 1986
- Seitenzahl: 528
- Erscheinungstermin: 31. Oktober 1986
- Englisch
- Abmessung: 266mm x 200mm x 33mm
- Gewicht: 1317g
- ISBN-13: 9780898387759
- ISBN-10: 0898387752
- Artikelnr.: 22923682
Surgical Decompression of Supratentorial Gliomas. Do the Results Justify the Opera-tion?.- 38. Laser Microsurgery: A Review of 110 Tumors of the Brain and Spinal Cord.- 39. Carbon Dioxide Laser Surgery For Malignant Glioma.- 40. Long Term Results of Ventricular Shunts Performed Prior to Posterior Fossa Operation for Tumor.- 41. Radical Laser Surgery in the Treatment of Gliomas.- 42. Preliminary Observation on the Use of the Local Thermochemotherapy in the Treatment of Malignant Cerebral Tumors.- 43. Remarks on the Surgical Treatment of Bilateral Transcallosal Gliomas.- Section V. The Biology of Radiotherapy.- 44. Radiation Damage to Brain and Cranial Soft Tissues: Outcome and Incidence Before and After Reduction in Dose.- 45. Radiotherapy with a Three-Fraction Per Day Regimen in a Split Course of Irradiation for Malignant High Grade Astrocytomas.- 46. Non-Invasive Thermochemotherapy for Advanced Brain Tumors.- 47. 252CF Neutron Brachytherapy for Malignant Glioma at the University of Kentucky and a Malig-nant Glioma Therapeutic Staging System.- 48. Permanent Radioactive Iodine Seed Implants Following Radical Resection in Recurrent Human Malignant High Grade Astrocytomas.- 49. Technique and Preliminary Results of Interstitial Irradiation for Recurrent Glial Tumors.- 50. Results of Definitive Irradiation for Optic Gliomas.- Section VI. Drug Therapy.- 51. Current Approaches to Chemotherapy.- 52. Cisplatin, Arabinofuranosyl Cytosine, and Caffeine Before Radiation for Glioblastomas.- 53. Multimodality Therapy of Supratentorial High-Grade Gliomas.- 54. The Use of Experimental Models of Human Medulloblastoma in the Design of Rational Therapy.- 55. Phase II Study of Novantrone (Mitoxantrone Hydorchloride) in Adults with Grade III
IV Astrocytomas.- 56. An Experimental Study of Xenografted Human Gliomas.- 57. Human Central Nervous System Pharmacology of Tiazofurin.- 58. Primary Therapy of Medulloblastoma with Surgery, Radiation, and Methotrexate and BCNU
A Pilot Study.- 59. Cyclophosphamide, Adriamycin, Vincristine, and Dexamethasone in the Treatment of Bulky Central Nervous System Lymphoma.- 60. Effect of Intracarotid Administration of BCNU in Rats.- 61. Intravenous and Subarachnoid Adriamycin in Experimental Meningeal Carcinomatosis: Tissue Concentration and Therapeutic Efficacy.- 62. Adriamycin in the Treatment of Malignant Meningiomas.- 63. Heterogeneity in Response of Short-Term Glioma Cell Cultures to Cytotoxic Drugs: Correlation of In Vitro Chemosensitivity and Relapse Free Interval.- 64. High Dose Polichemotherapy with Autologous Bone Marrow Transplantation in Recurrent Medulloblastoma. A Pilot Study.- 65. Phase I Study of Intraarterial Mitomycin-C for Recurrent Intracerebral Tumors.- 66. In Vitro Phase II Trial with the Human Tumor Stem Cell Assay as a New Brain Tumor Model for Drug Screening: Preliminary Results.- Section VII. Immunoneurobiology.- 67. Immunotherapy of Patients with Brain Tumors
Current Prospective.- 68. Effect of Interferons and an Interferon Inducer on Malignant Brain Tumors.- 69. Antigenic Heterogeneity of Human Glioma Tissue and Cell Lines (HGL) Defined by Monoclonal Antibodies (MAs).- 70. T-Cell Mediated Cytotoxicity in Human Glioma.- 71. Modulation of HLA-DR Expression and Growth Inhibition on Glioma Cells: Heterogeneous Responses to Interferon.
Surgical Decompression of Supratentorial Gliomas. Do the Results Justify the Opera-tion?.- 38. Laser Microsurgery: A Review of 110 Tumors of the Brain and Spinal Cord.- 39. Carbon Dioxide Laser Surgery For Malignant Glioma.- 40. Long Term Results of Ventricular Shunts Performed Prior to Posterior Fossa Operation for Tumor.- 41. Radical Laser Surgery in the Treatment of Gliomas.- 42. Preliminary Observation on the Use of the Local Thermochemotherapy in the Treatment of Malignant Cerebral Tumors.- 43. Remarks on the Surgical Treatment of Bilateral Transcallosal Gliomas.- Section V. The Biology of Radiotherapy.- 44. Radiation Damage to Brain and Cranial Soft Tissues: Outcome and Incidence Before and After Reduction in Dose.- 45. Radiotherapy with a Three-Fraction Per Day Regimen in a Split Course of Irradiation for Malignant High Grade Astrocytomas.- 46. Non-Invasive Thermochemotherapy for Advanced Brain Tumors.- 47. 252CF Neutron Brachytherapy for Malignant Glioma at the University of Kentucky and a Malig-nant Glioma Therapeutic Staging System.- 48. Permanent Radioactive Iodine Seed Implants Following Radical Resection in Recurrent Human Malignant High Grade Astrocytomas.- 49. Technique and Preliminary Results of Interstitial Irradiation for Recurrent Glial Tumors.- 50. Results of Definitive Irradiation for Optic Gliomas.- Section VI. Drug Therapy.- 51. Current Approaches to Chemotherapy.- 52. Cisplatin, Arabinofuranosyl Cytosine, and Caffeine Before Radiation for Glioblastomas.- 53. Multimodality Therapy of Supratentorial High-Grade Gliomas.- 54. The Use of Experimental Models of Human Medulloblastoma in the Design of Rational Therapy.- 55. Phase II Study of Novantrone (Mitoxantrone Hydorchloride) in Adults with Grade III
IV Astrocytomas.- 56. An Experimental Study of Xenografted Human Gliomas.- 57. Human Central Nervous System Pharmacology of Tiazofurin.- 58. Primary Therapy of Medulloblastoma with Surgery, Radiation, and Methotrexate and BCNU
A Pilot Study.- 59. Cyclophosphamide, Adriamycin, Vincristine, and Dexamethasone in the Treatment of Bulky Central Nervous System Lymphoma.- 60. Effect of Intracarotid Administration of BCNU in Rats.- 61. Intravenous and Subarachnoid Adriamycin in Experimental Meningeal Carcinomatosis: Tissue Concentration and Therapeutic Efficacy.- 62. Adriamycin in the Treatment of Malignant Meningiomas.- 63. Heterogeneity in Response of Short-Term Glioma Cell Cultures to Cytotoxic Drugs: Correlation of In Vitro Chemosensitivity and Relapse Free Interval.- 64. High Dose Polichemotherapy with Autologous Bone Marrow Transplantation in Recurrent Medulloblastoma. A Pilot Study.- 65. Phase I Study of Intraarterial Mitomycin-C for Recurrent Intracerebral Tumors.- 66. In Vitro Phase II Trial with the Human Tumor Stem Cell Assay as a New Brain Tumor Model for Drug Screening: Preliminary Results.- Section VII. Immunoneurobiology.- 67. Immunotherapy of Patients with Brain Tumors
Current Prospective.- 68. Effect of Interferons and an Interferon Inducer on Malignant Brain Tumors.- 69. Antigenic Heterogeneity of Human Glioma Tissue and Cell Lines (HGL) Defined by Monoclonal Antibodies (MAs).- 70. T-Cell Mediated Cytotoxicity in Human Glioma.- 71. Modulation of HLA-DR Expression and Growth Inhibition on Glioma Cells: Heterogeneous Responses to Interferon.